PT - JOURNAL ARTICLE AU - Liu, Yunxian AU - Ebinger, Joseph E. AU - Mostafa, Rowann AU - Budde, Petra AU - Gajewski, Jana AU - Walker, Brian AU - Joung, Sandy AU - Wu, Min AU - Bräutigam, Manuel AU - Hesping, Franziska AU - Schäfer, Elena AU - Schubert, Ann-Sophie AU - Zucht, Hans-Dieter AU - Braun, Jonathan AU - Melmed, Gil Y. AU - Sobhani, Kimia AU - Arditi, Moshe AU - Van Eyk, Jennifer E. AU - Cheng, Susan AU - Fert-Bober, Justyna TI - Paradoxical Sex-Specific Patterns of Autoantibodies Response to SARS-CoV-2 Infection AID - 10.1101/2021.07.15.21260603 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.15.21260603 4099 - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260603.short 4100 - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260603.full AB - Background Amidst the millions of individuals affected directly by the pandemic, pronounced sex differences in the susceptibility and response to SARS-CoV-2 infection remain poorly understood. Emerging evidence has highlighted the potential importance of autoimmune activation in modulating not only the acute response but also recovery trajectories following SARS-CoV-2 exposure. Given that immune-inflammatory activity can be sex-biased in the setting of severe COVID-19 illness, we deliberately examined sex-specific autoimmune reactivity to SARS-CoV-2 in the absence of extreme clinical disease.Methods We used a bead-based array containing over 90 autoantigens previously linked to a range of classic autoimmune diseases to assess autoantibody (AAB) titers in 177 participants. All participants had confirmed evidence of prior SARS-CoV-2 infection based on presence of positive anti-nucleocapsid IgG serology results (Abbott Diagnostics, Abbott Park, Illinois). We used multivariate analysis to determine whether sex-bias was associated with increased rates of AABs reactivity and symptom burden after SARS-CoV2 infection.Results 82.4% of AABs reactivity was associated with being male compared to 17.6% with female. We found a diversity of AABs responses that exhibited sex-specific patterns of frequency distribution as well as associations with symptomatology and symptom burden.Conclusion Our results reveal a remarkable sex-specific prevalence and selectivity of AAB responses to SARS-CoV-2. Further understanding of the nature of triggered and persistent AAB activation among men and women exposed to SARS-CoV-2 will be essential for developing effective interventions against immune-mediated sequelae of COVID-19.Competing Interest StatementCo-authors Petra Budde, Jana Gajewski, Manuel Bräutigam, Franziska Hesping, Elena Schäfer, Ann-Sophie Schubert, and Hans-Dieter Zucht work for Oncimmune, a company that performed the serological assays on the biospecimens that were collected for this study.Funding StatementThis work was supported in part by Cedars-Sinai Medical Center, the Erika J Glazer Family Foundation, the F. Widjaja Family Foundation, the Helmsley Charitable Trust, and NIH grant K23-HL153888.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written informed consent and all protocols were approved by the Cedars-Sinai institutional review board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for de-identified data may be directed to the corresponding authors (Jennifer E. Van Eyk, Susan Cheng, Justyna Fert-Bober) and will be reviewed by the Office of Research Administration at Cedars-Sinai Medical Center prior to issuance of data sharing agreements. Data limitations are designed to ensure patient and participant confidentiality.